期刊
CANCER BIOLOGY & THERAPY
卷 10, 期 11, 页码 1079-1080出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/cbt.10.11.14086
关键词
prostate cancer; pharmaco-genetics; prognosis; copy number alterations; androgen receptor; TMPRSS-ERG; PI3K pathways; NCOA2